Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
L-type and N-type high-voltage-activated calcium channels are critical components of the voltage-gated calcium channel (VGCC) family, serving as key regulators of calcium entry in excitable cells (Wikipedia, 2024). L-type channels (CaV1.1–CaV1.4) are primarily found in cardiac and smooth muscle, where they mediate excitation-contraction coupling, and in endocrine cells, where they regulate hormone secretion such as aldosterone (NIH, 2024). N-type channels (CaV2.2) are predominantly localized at presynaptic nerve terminals, where they trigger the release of neurotransmitters like norepinephrine and play a vital role in pain transmission and sympathetic nervous system activity (PubMed, 2019). Drugs that act as dual L/N-type blockers, such as cilnidipine, are utilized in the management of hypertension, offering advantages over L-type-selective blockers by suppressing sympathetic reflex activity and providing renoprotective effects through the dilation of both afferent and efferent renal arterioles (JAPI, 2024). These channels are also significant targets in the treatment of chronic pain and are being investigated for their roles in neurodegenerative and neuropsychiatric disorders (NIH, 2022). Structurally, these channels are heteromultimeric complexes consisting of a pore-forming alpha-1 subunit and auxiliary subunits that modulate channel kinetics and trafficking (StatPearls, 2023).
Blockade of the alpha-1 subunit of both L-type and N-type voltage-gated calcium channels, inhibiting the influx of calcium ions into cells.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L-type and N-type voltage-gated calcium channels (L/N-type VGCC).